Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
The Department of Pharmaceuticals proposes to bear 6% of the interest on loans up to Rs 8-10 crore for three years, through a public sector financial institution to be selected after open competitive bidding.
A Chinese scientist, He Jiankui, claimed last year that he had created the world’s first gene-edited babies using Crispr, to make them resistant to HIV, although that could make them more vulnerable to other diseases. He invited condemnation from around the world and exposed the dangers of unregulated gene editing.
The next wave of growth could come from increasing exports to large and traditionally under penetrated markets such as Japan, China, Africa, Indonesia, and Latin America, which would help the industry meet its aspiration of becoming the world's largest supplier by volume, according to pharma industry body Indian Pharmaceutical Alliance (IPA).
This is part of a broader strategy to reduce debt in the company’s capital structure after it borrowed more to help finance the Rs 4,600-crore acquisition earlier this year of Heinz India’s consumer wellness business. Zydus has approached larger rivals, such as Cipla and Sun Pharmaceutical Industries, besides financial investors.
The DoP secretary has told both the domestic and multinational pharma lobby groups along with the medical device industry to “strictly” comply with the code of ethics, added the same people. The pharma lobby groups and the medical devices lobby group have been asked to share their comments on the issue within a week.
The authority said it found it ‘surprising’ that the FMCG major had not added the tax cost and losses to prices of products between July 1 and November 14, 2017, but had chosen to do so from November 15, when it was supposed to have reduced prices due to the rate reduction to 18% from 28%.
Trustee-manager to plan new business satisfying Singapore Stock Exchange norms. Last month, the court questioned Fortis for using the Rs 4,600 crore to buy the assets from RHT. This had been done in a “hurried and clandestine manner” and is “required to be gone into,” the court had said.
Ministry sets up panel to suggest stronger criminal procedures against violators. At present, penalties for false claims include “imprisonment which may extend to six months, fine, or both” in the case of the first conviction. In the case of a subsequent conviction, imprisonment “may extend to one year, or fine, or both”.
Enhanced coverage under Ayushman Bharat as well as deeper expansion in smaller towns will help the hospital sector, said Crisil Ratings. The improvement in demand will also be driven by alterations made to healthcare delivery models by hospital chains to align with regulatory changes as well as factors like increasing lifestyle diseases and medical tourism.
The tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the United States Food and Drug Administration (USFDA), as per the company's announcement posted on the website of the US health regulator.
Eleven-year-old Sameer from Bihar’s Muzaffarpur district is suffering from aplastic anaemia, and needs Rs 12 lakh for a bone marrow transplant. You would think that’s not a big hurdle since his mother’s name figures in the list of Ayushman Bharat beneficiaries but unfortunately his condition isn’t covered by the scheme.
The outcome of this high-stakes case will be keenly watched in four countries — India, Malaysia, Singapore and Japan. On it depends the future of India’s second largest hospital chain, which is emerging stronger, following a prolonged and bruising custody battle. It will send strong signals about contract enforcement and commercial dispute resolution in India.
The coverage is also extended to children adopted through a legal process by employees, including single and same-sex LGBTI employees, the company said in a statement. The plan will be applicable with effect from January 1, 2020. The move, according to the company, "reaffirms its commitment towards Diversity and Inclusion"
The product will be manufactured at the company's Pithampur, Unit 3 facility, Lupin said in a filing to the BSE. The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.
The patent for the drug is held by Pharmacyclics for three to four more years in India. Pharmacyclics was globally acquired by US giant AbbVie in 2015 in a massive USD21 billion deal. Natco's latest move is consistent with its earlier launches and challenging the patents held on anti-cancer drugs by multinational drug companies.
